Cite
Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach.
MLA
Choi, Min Joo, et al. “Comparative Safety Analysis of MRNA and Adenoviral Vector COVID-19 Vaccines: A Nationwide Cohort Study Using an Emulated Target Trial Approach.” Clinical Microbiology & Infection, vol. 30, no. 5, May 2024, pp. 646–52. EBSCOhost, https://doi.org/10.1016/j.cmi.2023.12.010.
APA
Choi, M. J., Na, Y., Hyun, H. J., Nham, E., Yoon, J. G., Seong, H., Seo, Y. B., Choi, W. S., Song, J. Y., Kim, D. W., Kim, Y.-E., Jung, J., & Cheong, H. J. (2024). Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach. Clinical Microbiology & Infection, 30(5), 646–652. https://doi.org/10.1016/j.cmi.2023.12.010
Chicago
Choi, Min Joo, Yewon Na, Hak Jun Hyun, Eliel Nham, Jin Gu Yoon, Hye Seong, Yu Bin Seo, et al. 2024. “Comparative Safety Analysis of MRNA and Adenoviral Vector COVID-19 Vaccines: A Nationwide Cohort Study Using an Emulated Target Trial Approach.” Clinical Microbiology & Infection 30 (5): 646–52. doi:10.1016/j.cmi.2023.12.010.